CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH ASTERISKS (***), HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. SHARE...Share Purchase Agreement • October 15th, 2018 • Emergent BioSolutions Inc. • Pharmaceutical preparations • New York
This SHARE PURCHASE AGREEMENT is made as of August 28, 2018, by and among Adapt Pharma Limited, an Irish private company limited by shares (the “Company”), each Seller identified on Schedule I hereto (each, a “Seller” and collectively, the “Sellers”), Seamus Mulligan, an individual (“Sellers’ Representative”) and Emergent BioSolutions Inc., a Delaware corporation (“Buyer”). Certain capitalized terms used herein are defined in Article I.
